Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroaki Taguchi

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Therapeutic Delivery|July 31, 2012
Overview and outlook of Toll-like receptor ligand-antigen conjugate vaccinesYoshio Fujita, Hiroaki Taguchi
Chemistry Central Journal|August 25, 2011
Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticlesYoshio Fujita, Hiroaki Taguchi
Gastroenterology|August 25, 2020
An Unusual Cause of Right Lower Abdominal PainTetsuo Hasegawa, Tsuyoshi Yamane, Hiroaki Taguchi
Bioorganic & Medicinal Chemistry Letters|March 30, 2016
Development of an activity-based probe for amyloid β-hydrolyzing antibodiesHiroaki Taguchi, Yoshio Fujita, Yuko Tsuda
Gastroenterology|June 18, 2021
An Unusual Cause of Right Upper Abdominal PainTetsuo Hasegawa, Shinya Nagae, Hiroaki Taguchi
Scientific Reports|November 10, 2022
A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chainEmi Hifumi, Tamami Nonaka, Hiroaki Taguchi, et al.
International Journal of Molecular Sciences|November 26, 2022
Obtaining Highly Active Catalytic Antibodies Capable of Enzymatically Cleaving AntigensTamami Nonaka, Hiroaki Taguchi, Taizo Uda, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|July 14, 2012
[Anti-atherosclerotic effects of etanercept in rheumatoid arthritis patients]Hiroaki Taguchi, Kazuo Nishi, Takahiro Suzuki, et al.
FASEB Bioadvances|March 4, 2020
New technologies to introduce a catalytic function into antibodies: A unique human catalytic antibody light chain showing degradation of β-amyloid molecule along with the peptidase activityEmi Hifumi, Hiroaki Taguchi, Eiichi Toorisaka, et al.
The Journal of Rheumatology|May 1, 2024
Potential Efficacy of Janus Kinase Inhibitors in the Treatment of a Patient With Coexisting Peripheral and Axial Spondyloarthritis and Ulcerative ColitisSho Ishigaki, Nobuhiko Kajio, Noritada Yoshikawa, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Therapeutic Delivery|July 31, 2012
Overview and outlook of Toll-like receptor ligand-antigen conjugate vaccinesYoshio Fujita, Hiroaki Taguchi
Chemistry Central Journal|August 25, 2011
Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticlesYoshio Fujita, Hiroaki Taguchi
Gastroenterology|August 25, 2020
An Unusual Cause of Right Lower Abdominal PainTetsuo Hasegawa, Tsuyoshi Yamane, Hiroaki Taguchi
Bioorganic & Medicinal Chemistry Letters|March 30, 2016
Development of an activity-based probe for amyloid β-hydrolyzing antibodiesHiroaki Taguchi, Yoshio Fujita, Yuko Tsuda
Gastroenterology|June 18, 2021
An Unusual Cause of Right Upper Abdominal PainTetsuo Hasegawa, Shinya Nagae, Hiroaki Taguchi
Scientific Reports|November 10, 2022
A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chainEmi Hifumi, Tamami Nonaka, Hiroaki Taguchi, et al.
International Journal of Molecular Sciences|November 26, 2022
Obtaining Highly Active Catalytic Antibodies Capable of Enzymatically Cleaving AntigensTamami Nonaka, Hiroaki Taguchi, Taizo Uda, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|July 14, 2012
[Anti-atherosclerotic effects of etanercept in rheumatoid arthritis patients]Hiroaki Taguchi, Kazuo Nishi, Takahiro Suzuki, et al.
FASEB Bioadvances|March 4, 2020
New technologies to introduce a catalytic function into antibodies: A unique human catalytic antibody light chain showing degradation of β-amyloid molecule along with the peptidase activityEmi Hifumi, Hiroaki Taguchi, Eiichi Toorisaka, et al.
The Journal of Rheumatology|May 1, 2024
Potential Efficacy of Janus Kinase Inhibitors in the Treatment of a Patient With Coexisting Peripheral and Axial Spondyloarthritis and Ulcerative ColitisSho Ishigaki, Nobuhiko Kajio, Noritada Yoshikawa, et al.
Pageof 7